Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 2
1979 4
1980 2
1981 4
1982 2
1983 5
1984 2
1985 5
1986 3
1987 1
1989 3
1990 3
1991 5
1992 3
1993 5
1994 6
1995 7
1996 5
1997 15
1998 13
1999 12
2000 18
2001 26
2002 22
2003 23
2004 21
2005 26
2006 26
2007 28
2008 27
2009 27
2010 34
2011 45
2012 71
2013 77
2014 83
2015 125
2016 182
2017 164
2018 170
2019 178
2020 160
2021 134
2022 135
2023 121
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

1,753 results

Results by year

Filters applied: . Clear all
Page 1
Synthetic cannabinoid receptor agonists: classification and nomenclature.
Potts AJ, Cano C, Thomas SHL, Hill SL. Potts AJ, et al. Clin Toxicol (Phila). 2020 Feb;58(2):82-98. doi: 10.1080/15563650.2019.1661425. Epub 2019 Sep 16. Clin Toxicol (Phila). 2020. PMID: 31524007 Review.
Developed for legitimate scientific research, synthetic cannabinoid receptor agonists are potent agonists at CB(1) and CB(2) receptors and there have been many case reports of severe or fatal toxicity following their recreational use. ...PUBMED, Google Scholar and M …
Developed for legitimate scientific research, synthetic cannabinoid receptor agonists are potent agonists at CB(1) and CB(2) r …
Synthetic cannabinoid use disorder: an update for general psychiatrists.
Grigg J, Manning V, Arunogiri S, Lubman DI. Grigg J, et al. Australas Psychiatry. 2019 Jun;27(3):279-283. doi: 10.1177/1039856218822749. Epub 2019 Jan 21. Australas Psychiatry. 2019. PMID: 30663326 Review.
OBJECTIVE: Synthetic cannabinoid use disorder is emerging as a significant clinical issue. This article provides the general psychiatrist with an overview of the physical and psychiatric adverse effects of chronic synthetic cannabinoid use, as well as …
OBJECTIVE: Synthetic cannabinoid use disorder is emerging as a significant clinical issue. This article provides the general p …
Synthetic Cannabinoid-Associated Coagulopathy.
Kelkar AH, Tarantino MD, Roberts JC. Kelkar AH, et al. N Engl J Med. 2019 Jan 3;380(1):101-102. doi: 10.1056/NEJMc1814118. N Engl J Med. 2019. PMID: 30601754 No abstract available.
Synthetic Cannabinoid-Associated Coagulopathy.
Wang JJ, Howland MA, Biary R. Wang JJ, et al. N Engl J Med. 2019 Jan 3;380(1):101. doi: 10.1056/NEJMc1814118. N Engl J Med. 2019. PMID: 30601753 No abstract available.
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective.
Cohen K, Weinstein AM. Cohen K, et al. Front Public Health. 2018 Jun 7;6:162. doi: 10.3389/fpubh.2018.00162. eCollection 2018. Front Public Health. 2018. PMID: 29930934 Free PMC article. Review.
There is a growing use of novel psychoactive substances containing synthetic cannabinoids. Synthetic cannabinoid products have effects similar to those of natural cannabis, yet, these drugs are more potent and dangerous, and have been associated with dangerous adver …
There is a growing use of novel psychoactive substances containing synthetic cannabinoids. Synthetic cannabinoid products have …
Synthetic cannabinoid induced ocular self-injury.
Malik K, Kommana S, Paul J, Krakauer M. Malik K, et al. Orbit. 2021 Aug;40(4):326-328. doi: 10.1080/01676830.2020.1781199. Epub 2020 Jun 18. Orbit. 2021. PMID: 32552411
To our knowledge these are the first reports of ocular self-injury from synthetic cannabinoid intoxication....
To our knowledge these are the first reports of ocular self-injury from synthetic cannabinoid intoxication....
Synthetic Cannabinoid-Related Deaths in England, 2012-2019.
Yoganathan P, Claridge H, Chester L, Englund A, Kalk NJ, Copeland CS. Yoganathan P, et al. Cannabis Cannabinoid Res. 2022 Aug;7(4):516-525. doi: 10.1089/can.2020.0161. Epub 2021 Feb 24. Cannabis Cannabinoid Res. 2022. PMID: 33998886 Free PMC article.
Aim: To identify drug-related death trends associated with synthetic cannabinoid receptor agonists (SCRAs) reported to the National Programme on Substance Abuse Deaths (NPSAD) from England. ...
Aim: To identify drug-related death trends associated with synthetic cannabinoid receptor agonists (SCRAs) reported to the Nat …
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Wouters E, Walraed J, Banister SD, Stove CP. Wouters E, et al. Biochem Pharmacol. 2019 Nov;169:113623. doi: 10.1016/j.bcp.2019.08.025. Epub 2019 Aug 28. Biochem Pharmacol. 2019. PMID: 31472128 Review.
For a particular group of cannabinoid receptor ligands (i.e. CB(1)/CB(2) agonists), namely the synthetic cannabinoid receptor agonists (SCRAs), the research on biased signaling is still in its infancy and interesting outcomes are only recently being revealed. ...
For a particular group of cannabinoid receptor ligands (i.e. CB(1)/CB(2) agonists), namely the synthetic cannabinoid receptor …
1,753 results